| Product NDC: | 67386-122 |
| Proprietary Name: | NeoProfen |
| Non Proprietary Name: | ibuprofen lysine |
| Active Ingredient(s): | 10 mg/mL & nbsp; ibuprofen lysine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67386-122 |
| Labeler Name: | Lundbeck Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021903 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060413 |
| Package NDC: | 67386-122-52 |
| Package Description: | 3 VIAL in 1 CARTON (67386-122-52) > 2 mL in 1 VIAL |
| NDC Code | 67386-122-52 |
| Proprietary Name | NeoProfen |
| Package Description | 3 VIAL in 1 CARTON (67386-122-52) > 2 mL in 1 VIAL |
| Product NDC | 67386-122 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ibuprofen lysine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20060413 |
| Marketing Category Name | NDA |
| Labeler Name | Lundbeck Inc. |
| Substance Name | IBUPROFEN LYSINE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |